AU2021218456A1 - Methods of preparing chiral benzodiazepinone derivatives - Google Patents

Methods of preparing chiral benzodiazepinone derivatives Download PDF

Info

Publication number
AU2021218456A1
AU2021218456A1 AU2021218456A AU2021218456A AU2021218456A1 AU 2021218456 A1 AU2021218456 A1 AU 2021218456A1 AU 2021218456 A AU2021218456 A AU 2021218456A AU 2021218456 A AU2021218456 A AU 2021218456A AU 2021218456 A1 AU2021218456 A1 AU 2021218456A1
Authority
AU
Australia
Prior art keywords
compound
formula
solvent
combination
another embodiment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021218456A
Other languages
English (en)
Inventor
Christopher M. Cimarusti
Madan Raja Gopal Reddy DARAM
Anandkumar Madanlal LAHOTI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunome Inc
Original Assignee
Immunome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunome Inc filed Critical Immunome Inc
Publication of AU2021218456A1 publication Critical patent/AU2021218456A1/en
Assigned to IMMUNOME, INC. reassignment IMMUNOME, INC. Request for Assignment Assignors: AYALA PHARMACEUTICALS INC.
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/30—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2021218456A 2020-02-16 2021-02-16 Methods of preparing chiral benzodiazepinone derivatives Pending AU2021218456A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062977316P 2020-02-16 2020-02-16
US62/977,316 2020-02-16
PCT/US2021/018137 WO2021163676A1 (en) 2020-02-16 2021-02-16 Methods of preparing chiral benzodiazepinone derivatives

Publications (1)

Publication Number Publication Date
AU2021218456A1 true AU2021218456A1 (en) 2022-09-22

Family

ID=77291712

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021218456A Pending AU2021218456A1 (en) 2020-02-16 2021-02-16 Methods of preparing chiral benzodiazepinone derivatives

Country Status (11)

Country Link
US (2) US12503449B2 (https=)
EP (1) EP4107148A4 (https=)
JP (1) JP2023513731A (https=)
KR (1) KR20220143094A (https=)
CN (1) CN115103836A (https=)
AU (1) AU2021218456A1 (https=)
BR (1) BR112022016249A2 (https=)
CA (1) CA3171651A1 (https=)
IL (1) IL295572A (https=)
MX (1) MX2022010079A (https=)
WO (1) WO2021163676A1 (https=)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0253571B1 (en) * 1986-07-14 1989-08-23 Merck & Co. Inc. Process for resolution and race mization of amines with acidic alpha-hydrogens
NL9000386A (nl) * 1990-02-16 1991-09-16 Stamicarbon Werkwijze voor de bereiding van optisch aktief aminozuuramide.
JPH0751555B2 (ja) 1992-04-15 1995-06-05 キヤノン株式会社 ジイモニウム塩化合物
BRPI0520554A2 (pt) * 2005-09-19 2009-06-13 Arrow Therapeutics Ltd uso de uma benzodiazepina ou um sal farmaceuticamente aceitável do mesmo, método para tratar ou prevenir uma infecção por hcv em um paciente, derivado de benzodiazepina ou um sal famaceuticamente aceitável do mesmo, e, composição farmacêutica
WO2010073253A1 (en) 2008-12-22 2010-07-01 Natco Pharma Limited Method for preparing an optically active frovatriptan
WO2013148554A1 (en) * 2012-03-30 2013-10-03 Merck Sharp & Dohme Corp. Process for preparing fluoroleucine alkyl esters
CN105308030A (zh) * 2012-09-21 2016-02-03 百时美施贵宝公司 烷基、氟烷基-1,4-苯并二氮杂*酮化合物
EP2897942B1 (en) 2012-09-21 2016-08-31 Bristol-Myers Squibb Company Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds as notch inhibitors
WO2014047392A1 (en) 2012-09-21 2014-03-27 Bristol-Myers Squibb Company Fluoroalkyl-1,4-benzodiazepinone compounds
TWI614238B (zh) * 2012-09-21 2018-02-11 必治妥美雅史谷比公司 雙（氟烷基）－１，４－苯并二氮呯酮化合物及其前藥
JP6687596B2 (ja) 2015-02-17 2020-04-22 アモーレパシフィック コーポレーションＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ Ｎ−［４−（１−アミノエチル）−フェニル］−スルホンアミド誘導体のキラル分割方法
CN105439939B (zh) 2015-11-12 2018-12-04 四川恒康科技发展有限公司 一种(S)-N-Boc-3-羟基哌啶的合成方法

Also Published As

Publication number Publication date
CN115103836A (zh) 2022-09-23
MX2022010079A (es) 2022-09-02
US20250346565A1 (en) 2025-11-13
BR112022016249A2 (pt) 2022-10-11
CA3171651A1 (en) 2021-08-19
EP4107148A1 (en) 2022-12-28
WO2021163676A1 (en) 2021-08-19
EP4107148A4 (en) 2024-05-15
IL295572A (en) 2022-10-01
US20230108536A1 (en) 2023-04-06
US12503449B2 (en) 2025-12-23
KR20220143094A (ko) 2022-10-24
JP2023513731A (ja) 2023-04-03

Similar Documents

Publication Publication Date Title
JP4172717B2 (ja) 置換２，５−ジアミノ−３−ヒドロキシヘキサンの製造方法
KR20050030961A (ko) 변형된 픽텟-스펭글러 반응 및 그것으로부터 제조된생성물
MX2008003428A (es) Pirrolidin -2-onas sustituidas en la posicion 4 y sus usos.
US20210253523A1 (en) Brivaracetam intermediate, preparation method therefor, and preparation method for brivaracetam
CN102471272B (zh) 制备n-取代吡啶鎓化合物的方法和物质
KR20260042412A (ko) 피랄린 화합물, 및 이의 가압 반응조건에서의 제조방법
TW201718462A (zh) 用於製備有機化合物及中間物的方法
AU2021218456A1 (en) Methods of preparing chiral benzodiazepinone derivatives
García-Egido et al. Synthesis of cyanoformamides from primary amines and carbon dioxide under mild conditions. Synthesis of ceratinamine
KR100481570B1 (ko) 2-이미다졸린-5-온 제조용 중간체
US7514578B2 (en) Method for producing enantiomeric form of 2,3-diaminopropionic acid derivatives
CA2166061C (en) Novel processes for preparing (s)-4-amino-hepta-5,6-dienoic acid and intermediates thereof
JP7710717B2 (ja) 光学活性ピロリジン誘導体またはその酸性塩、光学活性α－カルボリン誘導体、およびそれらの製造方法
CN114085185B (zh) 制备贝达喹啉及其药学上可接受的盐的方法
US5786500A (en) Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane
JPH1059947A (ja) キラルで、非ラセミの（４−アリール−２，５−ジオキソイミダゾリジン−１−イル）酢酸の製造方法
WO2016203500A2 (en) Preparation of sacubitril or salt thereof and novel intermediates in the preparation of sacubitril
EP2938595B1 (fr) Procede de synthese d'une hydrazine utile dans le traitement du virus du papillome
CN117720540A (zh) 西格列汀中间体及西格列汀的制备方法
JP2023515000A (ja) パノビノスタットの製造方法
CN115335362A (zh) 手性胍及其盐、制备手性胍及其盐的方法以及手性胍及其盐在制备对映体纯氨基酸中的用途
WO2006093354A1 (ja) (ｓ)−２−[３−(ｎ−{[４−(４−フルオロフェノキシ)フェニル]メチル}カルバモイル)−４−メトキシフェニルメチル]ブタン酸の製造中間体
HK1101820A (en) Method for producing enantiomeric form of 2,3-diaminopropionic acid derivatives
HK1181382A (en) Process for the preparation of dimiracetam

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: IMMUNOME, INC.

Free format text: FORMER APPLICANT(S): AYALA PHARMACEUTICALS INC.